The Arizona Republic deserves real credit for finally asking a question that has been avoided for far too long: As states draw Colorado River water, what’s left for the river? That question alone ...
Clifton Powell is 69 years old and just now learning how to love. That confession hit hard during the “Black Men Trust Black Women Roundtable,” convened by SisterSong Executive Director Monica Simpson ...
Broadcom's ASIC chips don't compete as directly with Nvidia as GPU chipmakers like AMD do. The chipmaker told investors that its AI segment will double year over year in Q1. This massive growth comes ...
The U.S. economy experienced almost zero job growth in 2025, according to revised federal data. On a more encouraging note: Hiring has picked up in 2026. Preliminary data had indicated that the U.S.
Many parents and educators are concerned about standardized test scores released recently by the Missouri Department of Elementary and Secondary Education, and rightly so. Less than half of students ...
“Today’s blockbuster, expectation-shattering jobs report proves that President Trump’s economic agenda continues to pay off. The unemployment rate fell and private sector job growth remains robust — ...
Annual revisions show that employers added far fewer jobs in 2024 and 2025 than previously estimated. Change in nonfarm employment since Jan. 2023. Note: Data is seasonally adjusted. Source: Bureau of ...
WALTHAM, MASS. — Gov. Maura Healey’s new budget proposal for fiscal year 2027 includes a big change to MassHealth dental coverage with a $1,000 annual cap. State officials say it’s about controlling ...
Downgrading Hims & Hers Health, Inc. to Hold as the GLP-1 downside catalysts feel very real now. The FDA signaled new limits on non-approved compounded GLP-1 APIs being mass-marketed, and it ...
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Fans said lemme have some more, and Kourtney ...
Hims & Hers Health, Inc. is facing increasing regulatory pressure regarding its compounded GLP-1 offering. The GLP-1 revenue stream has been significant for HIMS, but not the only source of growth.